Patents by Inventor Katy Drieu

Katy Drieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a plant extract
    Publication number: 20060182821
    Abstract: The present invention is directed to the use of the extract of Ginkgo biloba leaves or isolated Ginkgolide B (GKB), a component of the extract of Ginkgo biloba leaves in a method for decreasing the expression of peripheral-type benzodiazepine_receptor (PBR) in cells of a patient in need thereof. Further, the present invention is directed to the use of the extract of Ginkgo biloba leaves or isolated GKB in a method for decreasing the proliferation of cancer cells in a patient. More particularly, the present invention is directed to the use of the extract of Ginkgo biloba leaves or isolated GKB in a method of decreasing cancer cell proliferation in a patient wherein the cancer cell is human breast cancer cell.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 17, 2006
    Inventors: Katy Drieu, Vassilios Papadopoulos
  • Use of Ginkgo extract
    Patent number: 7078434
    Abstract: The present invention is directed to the use of the extract of Ginkgo biloba leaves or isolated Ginkgolide B (GKB), a component of the extract of Ginkgo biloba leaves in a method for decreasing the expression of peripheral-type benzodiazepine receptor (PBR) in cells of a patient in need thereof. Further, the present invention is directed to the use of the extract of Ginkgo biloba leaves or isolated GKB in a method for decreasing the proliferation of cancer cells in a patient. More particularly, the present invention is directed to the use of the extract of Ginkgo biloba leaves or isolated GKB in a method of decreasing cancer cell proliferation in a patient wherein the cancer cell is human breast cancer cell.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: July 18, 2006
    Assignees: Societe de Conseils de Recherches et d'Applications Scientifiques SAS, Georgetown University
    Inventors: Katy Drieu, Vassilios Papadopoulos
  • Ginkgolides for inhibition of membrane expression of benzodiazepine receptors
    Publication number: 20050281899
    Abstract: Ginkgolides may be used to inhibit the membrane expression of a benzodiazepine receptor in a patient and in treatments to combat excess glucocorticoid production.
    Type: Application
    Filed: May 17, 2005
    Publication date: December 22, 2005
    Inventor: Katy Drieu
  • Use of Ginkgo biloba extracts for preparing a medicine
    Patent number: 6936285
    Abstract: The invention relates to the use of Ginkgo biloba extracts for preparing a medicament intended to ease the withdrawal of individuals dependent on the consumption of a substance engendering dependency and/or addiction, such as in particular alcohol, amphetamines, tobacco, drugs inducing toxicomania.
    Type: Grant
    Filed: December 1, 1998
    Date of Patent: August 30, 2005
    Assignee: Societe de Conseils de Recherches d'Application Scientifiques (S.C.R.A.S.
    Inventor: Katy Drieu
  • Use of extracts of ginkgo biloba for preparing a medicament
    Publication number: 20040180105
    Abstract: The invention relates to the use of Ginkgo biloba extracts for preparing a medicament intended to ease the withdrawal of individuals dependent on the consumption of a substance engendering dependency and/or addiction, such as in particular alcohol, amphetamines, tobacco, drugs inducing toxicomania.
    Type: Application
    Filed: March 25, 2004
    Publication date: September 16, 2004
    Applicant: SOCIETE DE CONSEILS DE RECHERCHES D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
    Inventor: Katy Drieu
  • Method of profiling a plant extract
    Publication number: 20030211456
    Abstract: The present invention is directed to a method of establishing an “identity” of Ginkgo biloba leaves or isolated ginkgolide B (GKB) or another component of the extract of Ginkgo biloba leaves, by obtaining a “gene regulation profile”. The invention is also directed to a method of verifying the identity of a Ginkgo biloba extract by comparing the gene regulation profile of a Gingko biloba extract of unknown or questionable origin with the gene regulation pofile of a Gingko biloba extract of known origin. The present invention is further directed to a method of establishing a gene expression profile of Ginkgolide A, Ginkgolide B or any other component isolated from a Ginkgo biloba extract, more particularly, from EGB 761®.
    Type: Application
    Filed: March 11, 2003
    Publication date: November 13, 2003
    Inventors: Vassilios Papadopoulos, Katy Drieu
  • Ginkgolides for inhibition of membrane expression of benzodiazepine receptors
    Publication number: 20020006955
    Abstract: Ginkgolides may be used to inhibit the membrane expression of a benzodiazepine receptor in a patient and in treatments to combat excess glucocorticoid production.
    Type: Application
    Filed: June 12, 2001
    Publication date: January 17, 2002
    Inventor: Katy Drieu
  • Ginkgolides for inhibition of membrane expression of benzodiazepine receptors
    Patent number: 6274621
    Abstract: This invention relates to the use of ginkgolides and extracts of Ginkgo biloba for inhibiting the membrane expression of benzodiazepine receptors and for inhibiting the release of glucocorticoids in a patient.
    Type: Grant
    Filed: July 23, 1998
    Date of Patent: August 14, 2001
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques, SAS
    Inventor: Katy Drieu